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Advisory Professor: Steven Norris, Ph.D.
B. burgdorferi, the causative agent of Lyme disease, have an elaborate antigenic
variation system that involves varying the sequence of vlsE. Previous studies have
shown that vlsE antigenic variation occurs continuously inside mammalian hosts.
Variation has not been shown previously to occur in in vitro or in ticks. We
hypothesized that the induction of vlsE recombination requires contact with dense
arrays of host tissue cells and/or ECM components. To test this hypothesis, two
methods, quantitative PCR and high-throughput sequencing were used determine the
extent and nature of vlsE recombination within mouse tissues and in vitro model
systems. Using these approaches, we were able to detect vlsE variants in axenic
cultures of B. burgdorferi as well as co-cultures with mouse skin and heart tissues;
these results were compared with those from mice infected for 7 days. Analysis of
PacBio single molecule real-time (SMRT) sequencing indicated the presence of 0.84%
to 1.18% variants in pure in vitro cultures and 0.79% to 1.22% in tissue explants, as
compared 36% to 57% for organisms from mouse bladder tissue 7 days post
inoculation. Statistical evaluation of the variants showed that the rate of
recombination in tissue explants was not significantly different from the rate of
recombination in in vitro cultures. Thus, tissue explant co-cultures do not seem to
promote a higher recombination rate than in in vitro axenic culture. Moreover, highthroughput PacBio sequencing was found to be an effective means of analyzing single
molecule sequencing variation in the robust vlsE antigenic variation system.
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Chapter 1
Introduction
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Borrelia Spirochetes
Borrelia is a genus that belongs to the spirochete phylum Spirochetes and the order
Spirochaetales [1]. Like Leptospira and Treponema, other members of the Spirochete
phylum, Borrelia are motile bacteria with a distinctive helical shape and an outer
membrane. Of all the members of the spirochete phylum, Borrelia species are the only ones
that require an arthropod vector for vertebrate host transmission. There are currently 36
known Borrelia species, and 15 Lyme disease species; the latter group is also known as
Borrelia burgdorferi sensu lato (“in a general sense”). It was proposed recently that the
Borrelia genus be reorganized into two genera: Borreliella for the Lyme disease group and
Borrelia for the relapsing fever organisms [2].
Lyme disease Borrelia
Of the B. burgdorferi sensu lato species, the three that cause the most human disease
are B. garinii, B. afzelii, and B. burgdorferi sensu stricto (“in a strict sense”) [1]. B.
burgdorferi sensu stricto is the predominant causative agent of Lyme disease in the United
States, although another species, provisionally called ‘Borrelia mayonii’, was recently
described [3]. Infections caused by B. garinii and B. afzelii are frequently found in Europe
and Asia.
Approximately 35,000 cases were reported to the Centers for Disease Control and
Prevention (CDC) in the year 2013. However, a recent analysis by the CDC indicated that
the actual incidence in the U.S. is over 300,000 cases per year [4]. Symptoms of Lyme
disease include skin lesions, arthritis, carditis, and neurologic deficits. The name of Lyme
disease originates from the town of Lyme, Connecticut, where clusters of pediatric and
adult arthritis cases were occurring [5]. These cases were studied and were thought to
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represent a new clinical entity, initially named Lyme arthritis. Later studies showed that
the syndrome was associated with the bite of Ixodes ticks, commonly resulting in a bullseye shaped rash called erythema migrans. The causative organism, later called B.
burgdorferi, was first cultured from ticks in 1981 [6].
Clinical manifestations of Lyme disease
Lyme disease as an illness can be divided into three stages, with each stage
presenting different clinical manifestations [7]. The early manifestations of Lyme disease
(stage one) include erythema migrans, low-grade fever, malaise and fatigue. Although the
lesions are localized, the organism has already begun to disseminate and can be isolated
from blood in many cases. The antibody response starts to develop, but is not consistently
detected in all patients. At the disseminated stage (stage 2) many patients experience
intermittent episodes of migratory musculoskeletal pain and attacks of asymmetric
arthritis in large joints, especially the knee. Eventually, the disease becomes persistent
(stage 3) and the episodes of arthritis become longer, lasting for months to years. Despite
the availability of effective antibiotic treatment for Lyme disease, some patients experience
post-treatment Lyme disease syndrome (PTLDS) where they continue to have symptoms.
PTLDS is a highly controversial topic in the scientific community; there is a no universally
accepted diagnosis and treatment for PTLDS. Moreover, the underlying mechanism of
PTLDS is unknown; some scientists believe that the post-infectious autoimmunity is the
cause of PTLDS, while others attribute the disease to persistent B.burgdorferi infection [8].
Diagnosis and treatment of Lyme disease
The diagnosis of Lyme disease is based primarily on clinical manifestations and
history, with support from serologic tests. In the U.S., a two-step laboratory testing process
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for Lyme disease is utilized [9]. First, an Enzyme-Linked Immunosorbent Assay (ELISA) is
performed to test the antibody response to a B. burgdorferi lysate or a mixture of
recombinant antigens. Then, those test samples with positive ELISA results are examined
by immunoblotting to detect IgM and IgG antibodies against individual Borrelia proteins. A
positive IgM immunoblot is only useful during the first 4-weeks of infection. IgG antibodies
are more reliable but can take 4-6 weeks to develop.
Treatment of Lyme disease consists of an initial 14 to 21 day course of oral
doxycycline or amoxicillin [10]. Some patients require an additional 30-day antibiotic
treatment. If patients have symptoms such as joint swelling or neuroborreliosis, they are
placed on a 4-week course of IV ceftriaxone therapy. These treatments are effective in
eradicating symptoms in most cases, but roughly 10% of patients have lingering symptoms
called post-treatment Lyme disease syndrome. New oral antibiotics approved by the FDA,
including daptomycin, carbomycin, have shown effectiveness against spirochetes in
culture, but there are no data yet to support if they work in patients with Lyme disease.
Borrelia burgdorferi genome
B. burgdorferi (Bb) has a highly unusual genome, consisting of a linear chromosome
and 21 circular and linear plasmids that range from 5 to 56 kilobases in size. Linear
plasmid names begin with lp, and circular plasmids begin with cp; both end with a number
that indicates the plasmid size in kilobases (e.g., lp54, cp9). B. burgdorferi strain B31 has a
linear chromosome of approximately 910 kb and 21 plasmids totaling 610 kb [11]. The
overall G+C content of the genome is 28.6%. Studies have shown that certain B. burgdorferi
plasmids are associated with infectivity. For instance, organisms lacking lp28-1 exhibit
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intermediate-infectivity (recovery of organisms up to two weeks after inoculation), while
the loss of lp25 results in low-infectivity phenotype [12, 13].
The chromosomes of all Borrelia organisms have a high degree of synteny [14].
Although the overall gene content of the plasmids of B. garinii, B. afzelii and B. burgdorferi
is generally well conserved, extensive intraplasmidic recombinations are evident in
different species and strains.
Vector tick Ixodes scapularis
Lyme disease is transmitted to humans by the bite of infected ticks of the genus
Ixodes. I. scapularis is the vector in the Eastern and North Central U.S., whereas I. pacificus is
the agent in the western U.S. I. ricinus and I. persulcatus are the vectors in Europe and Asia
respectively [15].
Lyme disease transmission cycle
The enzootic cycle of B. burgdorferi begins with eggs laid by adult female ticks in the
spring (Figure 1.1). The larvae hatch in the summer and can acquire Borrelia when they
take their first blood meal from infected small mammals or birds. After feeding, the larvae
molt and undergo metamorphosis into nymphal ticks. The ticks take a second blood meal
during the following spring. Nymphal ticks are able to transmit Borrelia to larger mammals
including humans and are responsible for the majority of Lyme disease cases. Humans are
an accidental host of Lyme disease and represent a ‘dead end’ in the transmission process.
Next, the nymphal ticks molt into the adult stage. Adult females feed on large mammals,
such as deer, and lay eggs in the spring, thus starting the two-year cycle all over again.
Adult female ticks can lay up to 3000 eggs and die just a few days afterwards [4].
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Differential expression of outer surface lipoproteins in B. burgdorferi during the
transmission cycle
During its transmission cycle, B. burgdorferi goes through many environmental
changes as it is transferred between the tick and mammalian hosts. Differential gene
expression of lipoproteins plays a major role in the ability of the organism to adapt to
different hosts [16]. As an example, outer surface protein A (OspA) is encoded on lp54 and
is predominantly expressed in the midgut of an infected unfed tick. When an unfed
nymphal tick begins to feed on a mammalian host, the environment in the midgut changes
from a pH of 7.4 to pH 6.8 and the temperature changes from ~22 ºC to near 37 ºC. During
feeding, OspA expression is down-regulated while OspC expression is up-regulated, and
spirochetes migrate from the midgut to the salivary glands. OspC plays an important role in
the transmission and initial dissemination of Borrelia from the tick in the mammalian host,
and its expression peaks after 48 hours of feeding [17].
Decorin-binding proteins DbpA and DbpB, also encoded lp54, are expressed during
mammalian infection but not in ticks [18]. These proteins mediate adherence to decorin, a
proteoglycan that ‘decorates’ the surface of collagen fibrils in some tissues. Tissues with
high decorin expression, such as skin, joints, and endothelium are thought to function as
protective niches for Borrelia. Another adhesive lipoprotein is BBK32. This protein binds to
glycosaminoglycans (GAGs) and fibronectin (Fn), a complex glycoprotein present in plasma
and extracellular matrix (ECM). Studies have shown that the interaction of BBK32 with
GAGs and Fn play an important role in the dissemination, colonization and persistence of
Borrelia in the mammalian host [19].
Overview of antigenic variation systems
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Antigenic variation is a mechanism by which an infectious agent can alter the
sequence of its antigenic surface proteins. The alteration of surface protein sequence
allows the infectious agent to escape the host immune response and thus promote longterm infection [20]. Antigenic variation systems hinder the development of vaccines for
many pathogens.
One example of a vector-borne pathogen that undergoes antigenic variation is
Trypanosoma brucei, a protozoan transmitted to mammals by tsetse flies. T. brucei
continuously switch their expression of variant-surface glycoproteins (VSGs) surface
protein [21]. Of the ~2000 VSG genes and pseudogenes, only one is transcriptionally active
while others remain silent. The silent VSG genes, which are located in clusters of large
arrays within the subtelomeric region of the 11 Mb chromosomes, can be copied into one of
15 telomeric VSG expression site (ES) through gene conversion. In early stages of infection,
an entire silent VSG gene replaces the ES. In the later stages of infection, segmental gene
conversion emerges as an additional mechanism of VSG switching. Segmental gene
conversion of multiple silent VSG genes can result in endless possibilities of new chimeric
VSGs.
Neisseria gonorrhoeae, a human pathogen that is the causative agent of the sexually
transmitted disease gonorrhea, also has an antigenic variation system that involves
variation of their Type IV pilin [21]. Segments of pilS silent cassettes are unidirectionally
transferred into the pilE expression locus through a gene conversion process. The copies of
pilS sequences are predominantly variable regions while the expressed pilE sequence
contains both variable and invariable regions. The recombination between pilS and pilE
involves replacement of pilE segments by pilS sequences, leaving the pilS sequence
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unchanged and creating a hybrid pilE sequence. The length and region of DNA replacement
in a recombination event can also vary. Recent data from the Seifert group showed that
pilin antigenic variation involves a guanine quartet (G4) structure [22]. Their later studies
showed that G-rich sequence can only form a G4 structure when a pilE G4-associated sRNA
was transcribed [23].
The causative agents of relapsing fever, such as Borrelia hermsii, also have antigenic
variation systems that involve varying variable major proteins (Vmps) [24]. B. hermsii
plasmids have a single Vmp expression site and ~40 silent gene segments that encode
variable large proteins (Vlps) and variable small proteins (Vsps). Gene conversion occurs
between a silent vsp or vlp gene segment and the expression site. Studies have shown that
the vlp or vsp sequence at the expression site is usually replaced completely by a silent vlp
or vsp gene segment [25]. This process involves recombination at upstream and
downstream homology sequences. Similar to B. hermsii, the antigenic variation system in
Borrelia burgdorferi involves gene conversion between the vmp-like sequence expression
site (vlsE) and the silent vls cassettes, as described below.
The vls antigenic variation system
The vls antigenic variation system was first described in B. burgdorferi in 1997 [26]
and is present in all Lyme disease Borrelia strains thus far characterized [27]. The gene
encoding the 35 kDa outer surface protein VlsE undergoes extensive recombination during
mammalian infection. In ticks and in in vitro culture, VlsE is expressed, but recombination
had not been detected in these environments prior to the research presented in this thesis
[28].
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The antigenic variation system of B. burgdorferi consists of varying the sequence of
VlsE, a surface localized lipoprotein [29]. The VlsE protein is encoded by vlsE, a gene
located on a 28 kb linear plasmid (lp28-1) in B. burgdorferi B31. The vlsE expression site is
downstream of 15 silent cassettes that are not expressed (Figure 1.2 A). There is 90% to
96.1% sequence homology between the 15 silent cassettes and the central cassette region
of vlsE. Each cassette has 6 variable regions (VRs) and 6 relatively invariant regions (IRs).
Most of the sequence differences between vlsE and the vls silent cassettes occur within the
6 variable regions (Figure 1.2 B). The recombination events include not only nucleotide
changes but also codon-length (multiple of threes) indels. There is 76.9% to 91.4%
predicted amino acid identity, consistent with the fact that most of the nucleotide
differences are non-synonymous. Figure 1.2 C shows an example of gene conversion events,
where portions of the central vlsE cassette region are replaced by segments of silent
cassettes 9, 7 and 10 sequentially. The first B. burgdorferi B31 vlsE allele described is called
vlsE1. All the vlsE recombination experiments reported herein use clones with the vlsE1
sequence; this sequence is therefore referred to as the parental sequence.
Previous studies in our laboratory [29], where 1,399 clones isolated from B.
burgdorferi B31-infected mouse tissues were analyzed, showed that there is an increased
frequency and complexity of vlsE sequence changes as the days post infection increase.
Immunocompetent C3H/HeN and severe combined immunodeficiency (SCID) mice were
infected with a B31 clone, and tissues from sacrificed mice were taken at days 4, 7, 10, 14
and 28 days post infection. Recombination events were observed in ~50% of organisms
recovered from infected C3H/HeN mice 4 days post inoculation, indicating that the
recombination process begins early in the course of infection. Borrelia clones with the
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‘parental’ vlsE sequence are cleared more rapidly in immunocompetent mice than in SCID
mice, indicative of immune elimination of clones with invariant VlsE sequences. By day 28
post-infection, no clones with the vlsE parental sequence were found in the
immunocompetent mice. In SCID mice, however, vlsE variants were isolated in increasing
numbers throughout the course of infection, but sequence changes accumulated more
gradually and clones with the parental sequence were still detected on day 28 postinfection. Thus, the presence of an adaptive immune response is not required to induce vlsE
recombination, but non-variant bacteria appear to be eliminated by the immune response.
Recombination events were distributed throughout the vlsE cassette, showing no
preference for a particular region within the cassette.
The length of recombination events ranged from single nucleotide change to almost
the entire vlsE cassette [29]. Due to high sequence homology among the silent cassettes, a
single silent cassette donor could not be identified unambiguously in some instances. Many
variant sequences resulted from multiple recombination events and thus resulted in
complex sequences with an untraceable lineage. Also, 15% of all the variant clones
analyzed had template-independent changes (usually single nucleotide substitutions),
meaning that these changes could not be explained as a gene conversion event between
vlsE and the 15 silent cassettes.
Gene conversion in Chicken immunoglobulin genes
As discussed in the previous sections, many pathogens including B. burgdorferi use
gene conversion as the mechanism to vary their antigens. Outside of pathogenic
microorganisms, gene conversion is used as the mechanism to expand and diversify the Bcell repertoire in Chickens [30]. Diversification of B-cells is essential in allowing the animal
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immune system to recognize and target a variety of invading bacteria and viruses. The
expansion of antibodies is the result of B-cells recombining their immunoglobulin genes:
variable (V), diversity (D) and joining (J). After V(D)J recombination, a unique VJ segment
is generated. In chicken B-cells; the VJ fragment undergoes gene conversion events, where
the upstream pseudo V segments act as the template for the unidirectional, segmental
recombination.
Characteristics of VlsE protein structure
VlsE is a surface-exposed lipoprotein that has a molecular weight of 35 kDa [26].
The crystal structure of VlsE [31] shows that the 6 variable regions form random loop
structures that comprise most of VlsE membrane-distal surface (Figure 1.3). It has been
postulated that the surface exposure of variable regions plays a role in hindering
interactions of host antibodies with the bacterial surface; this property may help Borrelia
evade the host immune response. The invariable regions have a structure made up
primarily of alpha helices with some beta-strands. Conserved N- and C-terminal regions
flank the central VlsE cassette and also have alpha helical structures.
Mechanism of vlsE recombination
Gene conversion, a mechanism that results in a unidirectional exchange between a
conserved DNA sequence and the ‘targeted’ DNA that undergoes sequence alteration, best
describes vlsE recombination, although non-templated point mutations have also been
shown to occur. Previous studies performed by our laboratory show that silent cassettes do
not change during recombination, further supporting gene conversion as the primary
mechanism of vlsE recombination [28]. Comprehensive studies, in which mutants of genes
known to be involved in DNA recombination and repair were analyzed, showed that genes
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ruvA and ruvB are important in vlsE recombination [32, 33]. RuvA and RuvB form a
complex that acts as the Holliday junction helicase during homologous recombination. ruvA
and ruvB mutants had a significantly lower rate of vlsE recombination in C3H/HeN mice. No
clones with variant vlsE sequences were recovered from ruvA or ruvB mutants in
immunodeficient (C3H/scid) mice 28 days post infection, further indicating that the
recombination rate was greatly reduced in these mutants. mutS mutants also displayed a
minor effect on vlsE recombination [33]. Mutation of the other genes examined, including
recA, did not have a significant effect on vlsE recombination rates [32-34]. Other than the
involvement of ruvA and ruvB and the potential involvement of mutS, the proteins and
recombinases involved in the vlsE recombination remain unknown.
vls sequences have an unusually high GC content of ~50% while the rest of the
genome has a GC content of ~28% [35]. There is also a high GC skew in vls sequences (with
a higher G content on the coding strand), which likely contributes to the recombination
process. It has been postulated that polymeric G stretches present in the vlsE cassette
region may promote the formation of secondary structures such as G-quadruplex within
vlsE, which could help mediate recombination at the expression locus [35]. Attempts to
mutate the vlsE locus (and thus identify cis-acting elements) have been unsuccessful to
date.
Unlike most antigenic variation systems, vlsE recombination has not been detected
in vitro [36] .This finding indicates that the activation of vlsE recombination may be
triggered by conditions specific to the mammalian host. One of the goals of this project was
to evaluate whether a tissue explant model system could provide a ‘tissue-like’
environment and thus induce a higher number of vlsE variants than in pure culture. If this
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were the case, the tissue explant system would provide a good in vitro model system to
study vlsE recombination, making the discovery of the trans-acting and cis-acting factors
involved in vlsE recombination much easier.
In this study, next-generation sequencing was used to generate a large number of
vlsE sequences. The availability of these data allowed us to thoroughly analyze the
occurrence of vlsE recombination in mammalian cell-free (axenic) cultures, tissue explant
co-cultures and infected mice. Besides examining the rate of recombination, we wanted to
analyze individual recombination events to see if any patterns emerged. Patterns in vlsE
variant sequences could lead to a better understanding of the nature and mechanism of
vlsE recombination.
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Figure 1.1 Life cycle of I. scapularis ticks and its relationship to Lyme disease
transmission
Blood-fed females lay eggs in late spring. In the summer, the eggs hatch into larvae, which
feed on Borrelia-infected small vertebrate hosts. In the spring of the following year, larvae
emerge as nymphal ticks. Typically, from May through June, infected nymphal ticks feed
and transmit B. burgdorferi to mammalian hosts. In the fall of year two, nymphs molt into
adults. The females feed on large mammals, mate and lay eggs. Humans are accidental
hosts, and are more likely to be infected by nymphs because ticks at this stage are smaller
and, therefore, harder to detect and remove. Furthermore, adult ticks do not commonly
feed on humans. (Figure from http://www.cdc.gov/ncidod/dvbid/lyme/ld_transmission.htm.)
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Figure 1.2 Characteristics of the vls locus and vlsE recombination [27]
A. vlsE is located on lp28-1, next to 15 silent cassettes that are highly homologous to each
other and to the central cassette region of vlsE. B. Each of the 16 cassettes has 6 variable
and 6 highly conserved invariant regions. The majority of variant or non-parental amino
acid sequences are within the variable regions. C. This panel shows a hypothetical example
of a homologous, unidirectional, random segmental recombination where vls9 first donates
part its sequence to the central region of vlsE. Then vls7 donates its sequence, replacing
part of the sequence that was donated by vls9. Lastly, vls10 donates its sequence to vlsE.
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Figure 1.3 VlsE protein structure [29]
a. The conserved N- and C- terminal regions are colored in gray. The variable regions are
located at the membrane distal surface and are colored in yellow. The 17-bp direct repeat
regions are shown in red.
b. VlsE sequence consists of a lipoprotein leader sequence (white) and conserved N- and Cterminal regions (gray). vlsE and the 15 silent cassettes are flanked by 17-bp non-
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conserved direct repeat sequence. Each cassette has 6 designated variable regions (yellow)
and 6 invariable regions (blue).
c. This image shows the crystal structure of VlsE. The localization of the variable regions to
the surface of the protein may act to protect the invariable regions from antibody
interaction.
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Chapter 2
Materials and methods
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Culture conditions
B. burgdorferi was grown in Barbour-Stoenner-Kelly (BSK) II medium that was
prepared in the laboratory [37]. The cultures were incubated at 37°C with 3% CO2, and cell
densities were counted under darkfield microscopy. Cultures were grown to late log phase
or early stationary phase, which has a concentration of 107-108 cells per ml.
Bacterial strains
B. burgdorferi B31-5A4, a clone that contains all plasmids and has a ‘parental’ allele
of vlsE1, is the bacterial strain that was used primarily in these studies. Strain B31 was
initially derived by Alan Barbour through a series of limiting dilutions of an extract from
ticks from Shelter Island, New York. The B31 strain had undergone three in vitro passages
when received by our laboratory, and is maintained as stocks at -80°C. B31-5A4 was
derived from B31 by two sequential colony isolations, and its plasmid content was
determined by polymerase chain reaction (PCR) [12]. This clone has been used previously
in animal infectivity studies, in vitro cultures and tissue explant experiments. 5A18NP1 is a
B31 clone with the ‘parental’ vlsE1 allele that lacks two plasmids (lp28-4 and lp56) and has
been further modified by disruption of BBE02 [38]. BBE02 and BBQ67 on lp56 encode type
2 restriction-modification enzymes, and their absence increases the transformation rate of
B. burgdorferi. 5A18NP1 exhibits an increased transformation efficiency and maintains full
infectivity in the mouse model [38]. 5A18NP1 was used in one of the mammalian cell-free
(axenic) culture studies.
Tissue explant model system
Dr. Diane Edmondson, a fellow lab member, designed the tissue explant model
system protocol. Small cubes (1-2 mm3) of mouse skin, heart, bladder, liver and spleen
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tissue were obtained aseptically from C3H/HeN mice. The explants were placed at the airliquid interface on a hydrated collagen matrix (Gelfoam; Upjohn) in 6 well cluster dishes
containing 1 ml BSK II medium per well. Explants were cultured at 37C in air-3% CO2 for 1
day prior to the addition of 5 x 105 B. burgdorferi (B31-5A4) per ml of medium. Starting on
Day 1 of co-culture, the medium was removed and then replaced with fresh medium every
2-3 days. At different time points, explants were removed for fixation and staining.
Genomic DNA was isolated from parallel samples.
Mouse infection studies
A total of 18 C3H/HeN immunocompetent female mice (6-8 weeks of age) were
used for the animal studies. A low passage frozen stock sample (2337C) of B31-5A4 was
selected and grown in BSK II medium to 107 organisms per ml. A volume of 0.1 ml
containing 105 organisms was used to inoculate the mice. Groups of 4 mice were sacrificed
on days 7, 14, 28, and 90-post infection (Figure 2.1). Five tissues (ear, joint, heart, bladder
and skin) were obtained from each of the mice sacrificed. The tissue specimens were
cultured for Borrelia in BSK II liquid medium with an antibiotic mixture (phosphomycin,
rifampicin, amphotericin B) to inhibit the growth of other bacteria. These cultures were
grown to 107 organisms per ml (approximately 7 days).
DNA preparation
All DNA extractions were done using the DNeasy Blood & Tissue kit (Qiagen). B.
burgdorferi were cultured in 6 ml liquid BSK II medium and grown to late log phase (~107
organisms per ml). B. burgdorferi cultures were centrifuged for 15 min at 4700 x g, and the
supernatant solution was discarded. Cells were resuspended in one ml of BSK II, vortexed
and transferred to 1.5 ml microcentrifuge tubes. The cells were centrifuged at 13200 x g for
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6 minutes at 4°C in an Eppendorf 5415R Centrifuge; the supernatant was discarded. The
centrifuged pellets were resuspended in 180 μl of buffer ATL and 20 μl of proteinase K,
which induces lysis of cells in order to release DNA, and were incubated overnight in a 56°C
water bath. The resulting lysates were then subjected to DNA purification according to the
manufacturer’s instructions and eluted in 150 μl of Tris acetate-EDTA buffer. The
concentration of the eluted DNA samples was determined using a NanoDrop
spectrophotometer, and the samples were stored at -20°C.
Amplification of vlsE cassette
The vlsE cassette region was amplified by using vlsE-specific primers. Both the
forward primer 4120 (5'-TAA GTA GTA CGA CGG GGA AAC CAG-3') and the reverse
primer 4066 (5'-CTT TGC GAA CTG CAG ACT CAG CA -3') are located outside of the 17bp direct repeat region at either end of the vlsE central cassette (Figure 1.3B). PCR
reactions were performed using Phusion, a high-fidelity DNA polymerase. Five μl of PCR
products were analyzed by gel electrophoresis on a 0.80% Agarose gel. Then, the PCR
products were purified using Qiagen’s PCR Purification kit.
PCR assay to detect vlsE recombination
To determine if vlsE recombination occurs within tissue explant co-cultures, a PCR
assay consisting of two primer pairs was used. Figure 2.1 shows the two primer pairs used
for the assay. The ‘parental’ primer pair has a forward primer sequence that is specific to
the ‘parental’ vlsE sequence in variable region (VR) 5, and will amplify any vlsE sequence
that has an unchanged VR5 region. The ‘variant’ primer amplifies vlsE sequences that have
undergone variation in VR5 and match the most common vls silent cassette sequence in
VR5. Note that the ‘variant’ primers will not be able to detect the presence of all variants,
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specifically those with a VR5 region identical to that of the parental sequence. Both primer
pairs have the same reverse primer, 4066, which is specific to the vlsE 3’ region.
Quantification of parental and variant vlsE sequences using Quantitative PCR
A quantitative PCR (qPCR) protocol was developed to quantify the copy number of
‘variant’ and ‘parental’ vlsE sequence in mammalian cell-free (axenic) cultures, tissue
explant co-cultures and infected mice DNA samples. All qPCR experiments were performed
using Bio-Rad SYBR Green PCR Master Mix and a Bio-Rad CFX96 Touch Real-Time PCR
Detection System. The same primer pairs used in the PCR assay to screen for vlsE
recombinants (Figure 2.1) were used in the qPCR experiments. To quantify the number of
non-variant and variant vlsE in a sample, qPCR reactions using both ‘variant’ and ‘parental’
primers were performed.
Pacific Biosciences sequencing
Pacific Biosciences (PacBio) methodologies and equipment were used to sequence
vlsE PCR products obtained from mice, tissue explant and in vitro samples. We are grateful
to Dr. George Weinstock and his team, who graciously performed the SMRTbellTM
procedure (see below) and PacBio sequencing. PacBio uses single molecule real-time
(SMRT) sequencing, which utilizes the inherent properties of the DNA polymerase as its
sequencing engine. Phospho-linked nucleotides are used to visualize polymerase activity,
with each of the four nucleotides (TAGC) attached to a different colored fluorescent label
(Figure 2.2). These phospho-linked nucleotides carry their fluorescent label on the
terminal phosphate rather than on the base, and DNA polymerase cleaves the fluorescent
label as the nucleotides are being incorporated. Sequencing is performed in SMRT cells,
each of which contains tens of thousands of zero-mode-wave-guides (ZMWs). Individual
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DNA fragments are sequenced simultaneously in the ZMWs, an optical waveguide
technology that guides light energy into a small volume, allowing the detection of
nucleotides being incorporated by the DNA polymerase one at a time. Once a nucleotide is
incorporated and the fluorescent label is cleaved off, the cleaved fluorescent molecule
diffuses out of the ZMW detection volume, making the fluorescent signal undetectable.
For amplicon sequencing, SMRTbellTM hairpin adaptors are ligated on to both ends
of each amplicon (Figure 2.3). The hairpin adaptors allow circular consensus sequencing
(CCS), where the forward and reverse strand of the each amplicon can be sequenced
multiple times. The shorter the amplicon, the higher number of repeated sequencing. Post
sequencing, a consensus read is generated by averaging the base calls of the multiple reads.
If performing multiplex sequencing, where multiple samples can be sequenced in parallel, a
barcode sequence is added to the SMRTbell adaptor. For our experiment, a unique barcode
was ligated to each of the 8 samples, and then the amplicons were pooled and sequenced.
PacBio has a mean read length of 10-15 kb and an error rate of 14% per single read. The
error rate can be reduced down to ~1% for consensus reads.
PacBio sequence data workflow
Initially, we attempted to align the raw consensus sequences against vlsE and vls
cassettes using ClustalW. The output was aligned very poorly, most likely due to a
combination of high homology among the cassettes, sequencing errors and threenucleotide indels. After failing to align sequences with other software programs, I decided
to manually align reads. Instead of attempting to manually align all reads (~30,000 per
sample), we focused on aligning variant reads. First, I filtered out sequences with read
lengths less than 601 bp or greater than 680 bp. This read length range was chosen
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because most likely anything less than 601 bp would be incomplete reads and reads longer
than 680 bp represented incorrect consensus assemblies and therefore would have too
many errors.
To identify variant sequences in the mammalian cell-free in vitro cultures and tissue
explant samples, BLAST searches using each PacBio sequence as the query sequence and
the invariant-variant regions (e.g. IR1-VR1) of vlsE1 and all of the vls silent cassettes as the
subject sequences were performed to identify PacBio sequences that contained regions
matching silent cassettes. All sequences that had a higher percent identity match with an
IR-VR sequence of one of the 15 silent cassettes was noted as a potential variant sequence.
All of the potential variant sequences were then manually aligned against pre-aligned vlsE1
and the 15 vls cassette sequences.
During the manual alignment process, the base positions of the deletion and
insertion errors were recorded and single base indel errors were manually corrected. For
ambiguous deletion errors, where different nucleotides are present in the cassettes, an
IUPAC code was used to represent the possible choices. Also, the most likely base was
determined by looking at the nucleotides and neighboring regions of vlsE and the 15 silent
cassettes around position as the error.
Automation of alignment and error correction
We collaborated with David Volk, Ph.D. to automate the alignment and error
correction process. The Aptaligner software utilizes the FASTQ file, a format that combines
the data of raw reads with quality information, as the input file. The program creates a
library that consists of all the codons in the vlsE parental sequence and the silent cassettes.
The raw reads were aligned simultaneously against vlsE codon sequence and all possible
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silent cassette codons using Hidden-Markov-Modeling (HMM). HMM optimizes the overall
read alignment by generating alignment scores for multiple alignment possibilities. Once a
possible alignment and its score are generated, the aligned sequence can only be replaced
with another aligned sequence of a higher score. The program also counts the number of
copies of identical reads and removes the non-unique sequences. Post-alignment, a
realignment script condenses equivalent alignments to optimize the subsequent error
correction script. Then error corrections are made by comparing codons at each position of
the read to the library of cassette codons. The program is designed to record the position
and the correction made. After the correction step, the aligned sequences are readjusted to
fix any misaligned regions. The realignment and correction steps of this program are
currently being optimized.
Analysis of aligned reads
Recombination events in aligned variant sequences were visualized using a Visual Basic
macros program [29] developed by Dr. Loic Coutte, a former lab member. This program
allowed us to visualize all potential vls cassette donors. It also distinguishes between a
maximal and minimal recombination event. Each cassette is represented by a different color.
Solid color regions indicate regions of the variant sequence that match that cassette (but not
the original vlsE1 sequence). The hatched color indicates that the variant sequence matches
both the vlsE1 and the cassette. A possible minimum recombination event represents the
largest area that matches a silent cassette region but not the parental vlsE1 sequence. In the
program, this region begins and ends with solid color regions, with hatched regions in all
intervening spaces. A potential maximal recombination event also includes flanking regions
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that match both the silent cassette and vlsE1. This region is the same as the minimal
recombination event plus the flanking hatched sequences.
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IR5
VR5
Cassette
151
152
153
154
155
156
157
Vlse1
GCT
GCT
GCT
ATT
GGG
GAT
AAA
Vsl2
GCT
GCT
GCT
ATT
GGG
AAG
GGT
Vls3
GCT
GCT
GCT
ATT
GGG
AAG
GGT
Vls4
GCT
GCT
GCT
ATT
GGG
AAG
GGT
Vls5
GCT
GCT
GCT
ATT
GGG
AAG
GGT
Vls6
GCT
GCT
GCT
ATT
GGG
GAT
AAA
Vls7
GCT
GCT
GCT
ATT
GGG
AAG
GGT
Vls8
GCT
GCT
GCT
ATT
GGG
AAG
GGT
Vls9
GCT
GCT
GCT
ATT
GGG
AAT
AAA
Vls10
GCT
GCT
GCT
ATT
GGG
AAG
GGT
Vls11
GCT
GCT
GCT
ATT
GGG
AAG
GGT
Vls12
GCT
GCT
GCT
ATT
GGG
AAG
GGT
Vls13
GCT
GCT
GCT
ATT
GGG
AAG
GGT
Vls14
GCT
GCT
GCT
ATT
GGG
AAG
GGT
Vls15
GCT
GCT
GCT
ATT
GGG
GAT
AAA
Vls16
GCT
GCT
GCT
ATT
GGA
AAG
GGT
The ‘Parental’ primer is indicated in red for vlse1, vls6, vls9 and vls15. The ‘Recombined’
primer is shown in green for vls2-vls5, vls7-vls8, and vls10-vls15. Vls16 does not fit either
primer due to codon 155.
Figure. 2.1 ‘Parental’ and ‘variant’ primer sequence used to detect presence
of vlsE recombinants in both PCR and qPCR assay.
The two primer pairs used to detect parental and variant vlsE sequences, were
specific to portions of the IR5 and VR5 region. This region was chosen because 12
out of the 15 silent cassettes had the seqeuence “AAGGGT” region in the
beginning of their VR5 region. The ‘parental’ vlsE has the sequence of “GATAAA“
in the beginning of its VR5 region. This difference allows the detection of most of
the vlsE variants that have undergone a change in the VR5 region.
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Figure 2.2 PacBio single molecule real-time (SMRT) sequencing [39]
(A) PacBio sequencing occurs within SMRT cells, each of which contains tens of thousands
of cylindrical zero-mode-waveguide (ZMW) units. Each ZMW has a single DNA polymerase,
which is fixed to the bottom, and a single DNA fragment.
(B) When the DNA polymerase incorporates a nucleotide, a laser light is passed through
the bottom of the ZMW cell, which allows the camera to detect the fluorescent signal
located the terminal phosphate of the dNTP. The intensity and the color of the signal are
recorded in real-time by the PacBio instrument. As the next nucleotide is incorporated, the
fluorescent label from the previous nucleotide is cleaved off and diffuses out of the cell.
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Figure 2.3 SMRTbell amplicon sequencing
In PacBio amplicon sequencing, SMRTbell hairpin adaptors (green) are ligated on to the
DNA fragment (yellow-purple). The SMRTbell dumbbell adapters allows the DNA
polymerase to sequence the DNA fragment in a circular motion, which in turn results in
multiple reads of the forward (yellow) and reverse (purple) strand of the amplicon. These
multiple forward and reverse subreads and are used to generate a circular consensus
sequence (black). (Figure from http://www.pacb.com/smrt-science/smrtsequencing/single-molecule-resolution/)
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qPCR results
Standardization of qPCR
The purpose of developing a qPCR assay was to use a sensitive method that would
accurately quantitate the number of variants in different samples and allow us find the rate
of vlsE recombination in in vitro, tissue explant and animal infection samples. To
standardize a qPCR protocol, the efficacy of three different primer lengths was tested. The
primer length of 21 bp was chosen because it produced standard curves with the highest
efficiency and R2 value (Figure 3.1). It also had the cleanest single peak melt curves (no
small shoulder peak that suggests the presence of secondary product). The qPCR
instrument’s thermal gradient feature was used find the optimal annealing temperature.
Serial dilution of 5A4 (parental vlsE clone) PCR product was used to generate a
standard curve for quantifying non-recombinant vlsE. The PCR product of a variant clone,
1396D, was used to construct standard curve for quantifying recombinant vlsE. 1:10 serial
dilutions between 0.5 ng/μl and 5 x 10-10 ng/μl were done for 5A4 and 1396d PCR
products. qPCR results yielded highly reproducible standard curves with high squared
correlation values (P21 R2=0.993, V21 R2=0.979) (Figure 3.1). It is important to note that
we were able to detect real variants in mammalian cell-free in vitro culture samples using
PacBio sequencing (Table 4). Therefore the PCR products from sample 2337C used to
construct the standard curve to quantitate copies of parental vlsE will contain a small
proportion of variant sequences. This might lead to a less precise calculation of the copies
of parental vlsE in samples.
CT values represent the cycle number at which the amplification fluorescent signal is
above the background fluorescence, i.e. the number of cycles it took to detect a real signal
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from a sample. The template DNA concentration for all samples was standardized to 5 ng.
The CT values represent the average of 3 technical replicates. Sample 2337C with P21
(parental primer) resulted in a CT value of 23.04 and a higher CT value of 27.77 with primer
V21 (variant primer) (Table 1). As expected, the reverse was true for the variant clone
sample 1396D, which had a CT value of 31.95 with primer P21 and a lower CT value of 18.91
with primer V21. TE47, tissue explant co-culture sample, had CT value of 24.10 with primer
P21 and CT value of 28.28 with primer V21.
qPCR reactions with template DNA from 7 (D7M1B), 14 (D14M1B) and 21
(D21M1B) days post infection mouse bladder tissue were also performed. The results
showed that as the days post infection increased, the CT value increased with P21, and the
decreased CT values with primer V21. These trends indicate that the proportion of
spirochetes with parental vlsE sequence decrease in mouse infection sample between 7 and
21 day post infection (Table 1).
Absolute quantification
For absolute quantification, the P21 standard curve was used to quantitate the
copies of parental vlsE and the V21 standard curve was used to quantitate the copies of
variant vlsE in a sample. First, the standard curve linear equation and CT values were used
to find the quantity in nanograms (ng) and then converted to copy number. The calculated
numbers of parental vlsE sequences and variant sequences detected using the V5 region
primers are provided in Table 2. As expected, 2337C had the highest number of parental
vlsE sequences and 1396D had the highest number of variant vlsE sequences detected.
Among the mouse infection samples, the copies of variant vlsE increased while the copies of
parental vlsE decreased over the days post infection.
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(A)

P21

E=99.6%
Standard

(B)

R2=0.993

Slope=-3.332

y-int=5.652

SYBR

V21

E=99.8%
Standard

R2=0.979

Slope=-3.328

SYBR
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y-int=6.326

Figure 3.1 Standard curves for absolute quantification using parental (P21) and
variant (V21) primers. The standard curve in panel (A) was generated with vlsE PCR
products from sample 2337C and P21 primer will be used to quantitate the copy number of
“parental” vlsE in a sample. While the standard curve shown in panel (B) was generated
using vlsE PCR product from sample 1396D and primer V21 will be used to calculate the
copies of variant vlsE in samples.
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Table 1. CT values with ‘parental’ primer P21 and variant primer V21.

Sample name

CT
Primer P21

CT
Primer V21

2337C

22.72 + 0.089

28.41 + 0.216

1396D

33.6 + 0.134

21.89 + 0.008

TE47

24.10 + 0.81

28.28 + 0.147

D7M1B

23.44 + 0.028

26.91 + 0.269

D14M1B

25.38 + 0.076

24.47 + 0.057

D28M1B

24.68 + 0.128

23.45 + 0.061
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Table 2. QPCR as a measure of vlsE recombination. Calculated copy numbers of parental
and variant vlsE Variable Region 5 (VR5) sequences were determined for in vitro cultures with
predominant parental (2337C) and variant (1396D) vlsE sequences, a tissue explant culture
(TE47), and in mouse bladder tissue 7, 14, and 28 days post inoculation with B. burgdorferi B31,
clone 2337C (D7M1B, D14M1B, and D28M1B, respectively).

Sample name

Copies with parental
vlsE VR5 sequences

Copies with variant
vlsE VR5 sequences

Proportion with
variant VR5 sequences
(%)

Parental clone (2337C)

3.49x104

1.07x103

2.97

Variant clone (1396D)

1.89x101

9.77x104

99.98

Tissue explant (TE47)

1.35x104

1.17x103

7.97

D7M1B

2.13x104

3.02x103

12.42

D14M1B

2.52x104

1.64x104

39.42

D28M1B

9.03x103

3.31x104

78.57
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Pacbio Results:
High-throughput sequencing was the second method used to quantitate the rate of
vlsE recombination in samples. NGS sequencing generates large amount of data, which
would allow us to accurately quantitate the number of variants, specifically those that
occur at very low rate (mammalian cell-free samples). Moreover, it allowed us to study
individual recombination events within variant sequences. PacBio sequencing was selected
as the sequencing platform because it has a long read length (10 kb - 15 kb), and low
consensus read error rate (~1%). 454 and Illumina have a comparable error rate but have
shorter amplicon read lengths (~ 300-600 bp) and therefore would not be able to sequence
the entire vlsE cassette. Moreover, 454 and Illumina synthesize DNA from clonally
amplified templates, which may result in sequencing bias. We filtered out reads less than
601 bp to eliminate reads that were shorter than the expected length of the vlsE cassette
plus the upstream and downstream regions (Table 3). Reads greater than 680 bp were also
filtered out to remove low quality reads that most likely resulted from misalignment of
SMRTbell subreads.
Error analysis
The SMRTbell approach provides multiple reads of both the forward and reverse
strands of each individual DNA molecule, and these sequences are then combined into a
consensus sequence. This redundancy greatly reduces, but does not eliminate, sequence
errors inherent to the PacBio sequencing process. To provide an initial assessment of the
presence of sequence errors, preliminary alignments of sequences from the 2337C sample
with the reference parental sequence (GenBank U76405) was performed. Because prior
Sanger sequencing of a 2337C vlsE PCR product matched U76405, it was expected that
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most, if not all, of the PacBio sequences would have the same sequence. However, it was
found that many of the reads had one or more sequence differences. Therefore a more
thorough analysis of the occurrence of sequence errors was done.
In this analysis, 127 reads from the 2337C sample were manually aligned with
U76405 and the 15 silent cassettes using the program BioEdit to determine the frequency
and locations of sequence differences. The total number of sequences with errors at each
position in aligned read was graphed. Error analysis of 127 reads from sample 2337C
showed that the positions with the highest frequency of errors were deletions of guanine
within polymeric G-runs (Figure 3.2). The positions that had errors in 20 sequences or
more are labeled above the corresponding bar. The locations of these common sequence
errors were consistent in the error analysis of manually aligned reads for the other
samples. In order to have a systematic approach when manually aligning sequences, the
guanine deletion errors within homopolymer runs were always assigned to the last G in the
stretch instead of being equally distributed among all the Gs. Therefore, the number of
errors at these terminal G positions are overstated while the number of errors of the nonterminal Gs in homopolymer runs are underreported. These results show that PacBio
sequencing errors in homopolymers are not random and instead occur at a higher rate
compared to errors at other positions. Fortunately, errors in homopolymer G runs are
easily fixed and hence the majority of the sequencing errors can be fixed unambiguously.
The error rate was calculated by dividing the total number of errors found in a
sequence by the read length of the aligned sequence (609 bp). To find the error rate of a
sample, the number of sequence differences of individual reads was averaged. In general,
errors could be distinguished easily from recombination events; nearly all were non-
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templated single base insertions or deletions, which were not observed previously in the
analysis of 1,496 clones by Sanger sequencing [29]. The error rate for manually aligned
reads ranged from 0.74% to3.2% (Table 4). The error rate could be related to the freshness
of the samples. The DNA from mouse infection samples was derived from spirochetes
grown out from tissue in BSKII medium, while the remaining samples were from stored
frozen cultures or DNA. This could explain why D7M1B reads had the lowest error rate
(Table 4).
Because most of the sequences contained errors, it was important to do an error
analysis that showed the sequence changes are a result of recombination events. First, the
mismatch, deletion and insertion error rate was calculated at several non-variant codon
positions (same codon sequence across vlsE and 15 silent cassettes). For example, the
codon at position 49 (Figure 3.4B) is a non-variant codon that has ‘AGT’ across all 16
cassettes. The mismatch error rate represents the inherent error rate per base present in
the sequences. Sample 2337C had 0.023% mismatch error rate, 0.40% deletion error rate,
and 0.20% single insertion error rate. Given the mismatch error rate of 0.023%, the odds of
a vlsE sequence without any mismatch errors is 0.977. I then compared the mismatch error
rate against the rate of change of bases at variant codon positions from a vlsE sequence to
one of the 15 vls sequences. For instance, for sample 2337C variants, the rate of change at
codon 38 was 11%. 11% is much higher than the calculated mismatch error rate of 0.023%,
therefore the sequences with changes at codon 38 are real changes and not result of errors.
Overall, this error analysis proves that the probability of having random base changes is
extremely low and therefore most of the changes in the variant sequences result from
recombination event(s).
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FASTQ analysis
In order to evaluate the quality of PacBio consensus sequences, FASTQ files of each
sample were analyzed. FASTQ files contain the quality scores associated with each base call
for every read. The quality scores were represented as ASCII characters and the ASCII table
was used to convert the ASCII characters into a phred or Q score. Essentially, the quality
scores represent the probability of a base being called incorrectly. This probability is
calculated using the formula P = 10–Q/10, where P is the error probability and Q is the
quality score.
The majority of the base calls had the ASCII character of K (corresponding to the
11th highest quality score and P_error= 0.07943). This was true for FASTQ files for all the
samples. In order to evaluate the quality of individual reads, a quality ratio was generated
for every sequence. The quality ratio was calculated by dividing the total number of bases
with the ASCII score of K or higher by the total read length. Figure 3.3 shows that there is a
negative correlation between the quality ratio and the total number of errors in a read. As
the total number of errors in a sequence increases, the quality ratio decreases. The
correlation between these two variables indicates that the quality ratio could be used to
accurately assess the quality of a read and ultimately help filter out low quality sequences.
Detection of real recombination events
Sequences that appeared to contain recombination events were identified by local
BLAST searches of each read against segments of the vlsE1 cassette region and the 15 vls
silent cassettes (see Materials and Methods). Those sequences that contained regions that
had higher sequence identity with a silent cassette segment than with the parental vlsE
sequence were considered to have potential recombination events. These were further
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verified through manual alignments. Because of their relatively small number, all of the
potential variants could be analyzed in the 2337C, 5A18NP1, and the infected tissue
explant TE47, TE49, TE50 samples. For day 7 mouse bladder samples, which contained a
high number of variants, the first 200 sequences were analyzed by manual alignment. The
percentage of variants was 0.84% to 1.18% in pure in vitro cultures derived from parent
strain B31, and 0.79% to 1.22% in the tissue explant co-culture (Table 4). In contrast, 36%
to 57% of the first 200 sequences from day 7 mouse bladder samples were variants. Within
the population of variants the number of variants with siblings (identical variant sequences
within the same sample) were counted. 11 to 63 variants with siblings were found in the 4
samples analyzed (Table 4). Thus most (67 to 91 percent) of the variant sequences
identified in this analysis were unique.
After manually aligning potential variant reads, the reads were entered into a Visual
Basic macros program. This program visually displays all potential silent cassette donors
that match the non-parental sequence of variant sequences. The length of recombination
events ranged from a single nucleotide change to almost the entire cassette. Figure 3.4
shows the Visual Basic macros program output for one variant read from sample 2337C.
Figure 3.4A shows the overall pattern of recombination in read 2337C_139710, whereas
Figure 3.4B provides a close-up of the variant region. The different colored bars represent
silent cassettes 2-15. The solid color represents where the variant sequence matches to a
silent cassette, while the surrounding lighter hatched colored region represents where the
variant sequence matches both the silent cassette and vlsE1. Therefore, the maximal
recombination event is inclusive of the surrounding lighter colored regions, while the
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minimal recombination event starts at the first change that is unique to a silent cassette
(solid color) and ends at the last change that is unique to the same silent cassette.
In many cases, a single vls cassette could be deduced as the donor to a
recombination event. For example, read 2337C_139710 has non-‘parental’ sequence within
its VR1 region (Figure 3.4A). The putative cassette donor for this variant sequence is vls3
because it encompasses all the non-‘parental’ sequence of the aligned variant read in one
consecutive segment. The minimal recombination event extends from codon 39 to 42,
while the maximal recombination event extends from codon 9 to 68. Figure 3.5 shows the
schematic representation of three additional variants from sample 2337C. Read
2337C_42395 has a single well-defined recombination event with a minimal recombination
event length of a single nucleotide (Figure 3.5A). The putative cassette donor is vls2. Read
2337C_103644 also has a single well-defined recombination event; vls3 is the putative
silent cassette donor and it has a 486-nucleotide long minimal recombination event. In
contrast, read 2337C_101310 has several intermittent sequence differences that can be
considered multiple recombination events (Figure 3.5B). Furthermore, most of the
changes in 2337C_101310 cannot be attributed to a single silent cassette, due to the
redundancy that occurs within regions of the silent cassettes.
Analysis of manually aligned variant reads
Variants reads were translated to their protein sequence and then compared against
the ‘parental’ vlsE sequence. The sequences with a non-parental amino acid at each position
were totaled. Results showed that, as expected, the majority of the non-parental amino
acids, or recombination events in variant sequences were within the variable regions
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(Figure 3.6). This is consistent with prior studies that also showed that most sequence
changes are concentrated in the variable regions [29].
To study the length of individual recombination events, variant sequences with a
single well-defined recombination event were further examined. The length of the single
recombination event and the putative silent cassette donor was recorded for all variant
sequences. The average length of a minimal recombination event of variants from sample
2337C was 48 codons, 33 codons for sample 5A18NP1, 3 codons for sample TE47, and 7
codons for sample D7M1B. The longest length of a minimal recombination event was 172
codons (the entire length of vlsE is 203 codons) for variants with single well defined
recombination events from both mammalian-cell free in vitro samples: 2337C and
5A18NP1. In contrast, the longest minimal recombination event was 35 codons long for
both TE47 and D7M1B (Figure 3.7A). The results indicate that variants from mammalian
cell-free (axenic) samples had a higher frequency of longer minimal recombination events
than the variants from tissue explant co-cultures and infected mice samples (Figure 3.7A).
Figure 3.7B shows the usage of silent cassettes in variant sequences with single
recombination events. While most sequences changes in aligned variant reads with a single
recombination event could be attributed to one of the 15 silent cassettes, some of the
sequences had template-independent changes, or apparent point mutations. It is unclear
whether these all these sequence differences represent a real genetic change or a
sequencing error.
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Table 3. Total number of reads obtained and number of reads that had a read length of >
601 bp and < 680 bp.
Sample name

Total number of reads

Number of reads > 601 bp
and < 680 bp

Parental clone (2337C)

35,699

15,184

Parental clone (5A18NP1)

29,259

12,136

Tissue explant (TE47)

29,536

12,762

Tissue explant (TE49)

23,913

11,076

Tissue explant (TE50)

31,861

14,025

D7M1B

24,042

10,036

D7M2B

20,601

8,393

D7M3B

28,981

10,875
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(A)

(B)
>vlsE1
GAGGGGGCTATTAAGGAAGTTAGCGAGTTGTTGGATAAGCTGGTAAAAGCTGTAAAGACAGCTG
AGGGGGCTTCAAGTGGTACTGCTGCAATTGGAGAAGTTGTGGCTGATGCTGATGCTGCAAAGGT
TGCTGATAAGGCGAGTGTGAAGGGGATTGCTAAGGGGATAAAGGAGATTGTTGAAGCTGCTGGG
GGGAGTGAAAAGCTGAAAGCTGTTGCTGCTGCTAAAGGGGAGAATAATAAAGGGGCAGGGAAGT
TGTTTGGGAAGGCTGGTGCTGCTGCTCATGGGGACAGTGAGGCTGCTAGCAAGGCGGCTGGTGCT
GTTAGTGCTGTTAGTGGGGAGCAGATATTAAGTGCGATTGTTACGGCTGCTGATGCGGCTGAGC
AGGATGGAAAGAAGCCTGAGGAGGCTAAAAATCCGATTGCTGCTGCTATTGGGGATAAAGATGG
GGGTGCGGAGTTTGGTCAGGATGAGATGAAGAAGGATGATCAGATTGCTGCTGCTATTGCTTTG
AGGGGGATGGCTAAGGATGGAAAGTTTGCTGTGAAGGATGGTGAGAAAGAGAAGGCT
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Figure 3.2 Nucleotide positions with the highest number of errors were deletions of
guanines in homopolymer G-runs.
(A) This error analysis graph represents the 127 variants sequences from sample 2337C.
The total number of errors was calculated at each position in the aligned sequence. The
positions with highest number of errors were homopolymer G-runs. The bars that have
position numbers above the peak represent these positions. For polymeric G-runs, the
deletion error was always assigned to the last G base in the run, and not rationed equally
across all of the Gs. Therefore, the error rate for the last G is overstated and under-reported
for the other Gs in the G-run.
(B) The homopolymer G-runs within vlsE1 sequence are underlined and positions with
highest number of errors are in red. vlsE is highly GC rich and has a total of 12 guanine
homopolymer runs. PacBio sequencing appears to have a sequencing error bias in
homopolymer runs.
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Figure 3.3 There is an inverse correlation between the quality score and total
number of errors.
This graph analyzes variant sequences from sample 2337C. The quality ratio was calculated
by dividing the total number of base calls with ASCII quality score of K or greater by the
total read length. The quality ratios for sequences with the same number of errors were
averaged. There is a negative correlation between the number of errors and the average
quality ratio. Sequences with higher numbers of errors tend to have a lower quality ratio,
while sequences with low numbers of errors tend to have a higher quality ratio. This
correlation suggests that FASTQ will be useful for identification and filtering of low quality
reads.
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Table 4. Percent variants detected in samples and the calculated error rate. The error rate
of each sample was calculated by averaging the error rate of individual variant reads. The
error rate of a single sequence is the total number of errors divided by the read length.
Sibling sequences are sequences that have the same vlsE variant sequence.
*Number of reads from TE49 and TE50 samples were additionally filtered for high quality
scores.
Sample name

Number of
variants

Percent of
variants

Error rate

2337C

Number of
reads > 601
and < 680
15,184

127

0.84%

1.58%

Number of
sequences
with siblings
14

5A18NP1

12,136

143

1.18%

2.5%

14

TE47

12,762

102

0.80%

3.2%

11

TE49

11,076

127

1.02%

0.89%

63

TE50

14,025

126

1.22%

0.74%

57

D7M1B-1st
200 reads

200 (1st 200
reads > 601
and < 680)

114

57%

0.96%

17

D7M2B-1st
200 reads

200 (1st 200
reads > 601
and < 680)

72

36%

0.92%

21

D7M3B-1st
200 reads

200 (1st 200
reads > 601
and < 680)

105

52.5%

1.01%

14
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Table 5. Chi-square test using in vitro and tissue explant samples
*The Day 7 Mouse samples are excluded from this analysis.
Item

Group-1 (in vitro culture)

Group-2 (tissue explant)

Total

0.99%

0.94%

1.93E-02

1.0%

1.01%

2.02E-02

O-E

-0.02%

-0.08%

-9.46E-04

(O-E)2

3.64E-08

5.70E-07

6.06E-07

(O-E)2 / E

3.61E-06

5.63E-05

5.99E-05

Observed
numbers (O)
Expected
numbers (E)

Critical Chi-square statistic for DF = # of groups -1= 2-1 =1 and 5% significance level
Conclusion:
As the calculated chi-square statistic (5.99E-05) is less than the Critical Chi-square statistic (3.84),
the Null Hypothesis can't be rejected.
Thus, it can be concluded that the number of variants found tissue explant samples (Group-2) is not
statistically different the number of variants found in in vitro culture samples (Group-1).
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Figure 3.4 Visual representation of a vlsE variant and all potential silent cassette donor
(A)

The variant read 2337C_139710 has a single recombination event within VR1 with

the minimal recombination event length of 4 codons. The putative cassette donor is vls3
because it contains the longest contiguous matching segment.
(B)

The bottom panel shows the magnified VR1 region of 2337C_139710 recombination

pattern and where it matches vls3. The top table shows the vlsE, 15 silent cassettes and the
2337C_139710 sequence. The brown solid colored regions represent where the change in
2337C_139710 is present in vls3. The lighter colored hatched region adjacent to solid
colored region are identical to vlsE1, the vls3 silent cassette and the variant sequence. The
yellow boxed regions indicate where 2337C_139710 matches vls3 sequence. The
recombination event most likely used vls3 as a template, because it is the only silent
cassette that matches all three codon changes.
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Figure 3.5 Visual representation of three vlsE variants and all potential silent
cassette donors.
(A) The variant read 2337C_127488 has a single recombination event within VR1 with the
minimal recombination event length of a single nucleotide. The putative cassette donor is
vls3 (orange) because it is the only cassette that matches that sequence change.
(B) Read 2337C_103644 has a single, long, well-defined recombination event that has a
minimal recombination event that extends from VR1 to VR6, and has a length of 486
nucleotides. The putative donor is vls3 (brown) because it is the only silent cassette that
matches the entire range of the recombination event.
(C) Variant read 2337C_101310 has multiple recombination events. The deduced number
of recombination events is 4 because there are 4 intermittent segments that match silent
cassettes. A single putative cassette donor cannot be determined for 3 of the 4 sequence
changes. vls2 is the most likely donor for the right-hand recombination event spanning
from VR3 to VR4.
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Figure 3.6 Majority of non-‘parental’ amino acid sequences in variant sequences
were within the expected lengths of the variable regions.
The variant nucleotide sequences were translated into amino acid sequences and then
compared against the parental vlsE amino acid sequence. The majority of the positions with
non-parental amino acid sequence were within the variable regions.

56

VR6

(A)
1

0.9

Frequency proportion

0.8
0.7

2337C-frequency
TE47-frequency

0.6

D7M1B-frequency

0.5

5A18NP1-frequency

0.4

2337C-cumulative freq
TE47-cumulative freq

0.3

D7M1B-cumulative freq

0.2

5A18NP1-cumulative freq

0.1
0
1

11

21

31

41

51 61 71 81 91 101 111 121 131 141 151 161 171
Length of minimal recombination event

57

(B)
0.3

Frequency proportion

0.25

0.2

2337C
0.15

5A18NP1
TE47

0.1

D7M1B
0.05

0
2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

pm

Silent cassette

Figure 3.7 Lengths of minimum recombination events in variant sequences with a
single, well-defined recombination event.
(A) For each sample, the length of the minimal recombination event in variant sequences
with a well defined single recombination event was graphed against the frequency
proportion. The cumulative frequency of sequences that have a minimal recombination
event length that is less than or equal to a set length is shown by the line graph.
(B) Along with the length of the minimal recombination event, the deduced cassette donor
for variant sequences with a single recombination event were counted and graphed. Some
sequences with a single recombination event had a single nucleotide change as point
mutations (pm).
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Chapter 4
Discussion
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Both qPCR and high throughput sequencing were effective methods in
detecting and quantifying vlsE variants. This is the first time vlsE recombination has
been shown to occur in in vitro mammalian cell-free cultures and tissue explant cocultures. In both methods, the difference in the number of variants found in axenic in
vitro samples and tissue co-culture samples was not statistically significant. The
results from the previous chapter suggest that not only is there a difference in the
rate of recombination among axenic culture, tissue explant co-culture and infected
mice samples, but there is also a difference in the nature and extent of antigenic
variation.
qPCR results
We were able to standardize a qPCR protocol that allowed us to use absolute
quantification to compare the rate of vlsE recombination in axenic, tissue explant coculture and animal infection samples. Two primer pairs were used, one for detecting
parental vlsE and the other for detecting variant vlsE. Both primer pairs are specific
for detecting whether the VR5 region has undergone a change. The variant primer
detects variants with a change in VR5 region; therefore the parental primer and not
the variant primer will amplify any variants with an unchanged VR5 region. Given
that 12 of 15 silent cassettes have a VR5 sequence that differs from the parental
sequence at the priming site, a positive PCR result would be expected in ~80% of
clones with a recombination event in the region. In addition, recombination events
occurring in other portions of the vlsE cassette region would not be detected by this
method. Therefore this qPCR method provides an indication of the extent of
recombination in a B. burgdorferi population, but does not provide an estimate of, for
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example, the proportion of clones that have a recombination event in any location
within the vlsE cassette.
The optimized qPCR assay had linear standard curves with R2 values > 0.979,
high amplification efficiency (> 99%), and consistency across replicates. Using
absolute quantification standard curves, we found that the percentage of variants
was 2.97% in sample 2337C, 99.98% in 1396D, 7.97% in TE47, 12.42% in D7M1B,
39.42% in D14M1B, 78.57% in D28M1B (Table 3.2). Comparing the percent of
variants found in samples 2337C and TE47, the difference was not statistically
significant. Similar to the results observed in prior studies, the qPCR assay showed
an increase in the accumulation of variants between day 7 and day 28 post-infection
in mice. However, the percentage of variants calculated by qPCR absolute
quantification in sample 2337C and TE47 was higher than the percentage of variants
found by high-throughput sequencing. This is most likely the result of the inherent
differences between the two methodologies.
PacBio sequencing results
High-throughput sequencing of vlsE PCR products generated a large amount
of data with approximately 30,000 reads per sample. Despite the presence of
sequencing errors, we were able to manually align sequences against 16 pre-aligned
cassettes. The error analysis showed that we were able distinguish real vlsE variants
from sequence errors. The majority of sequencing errors are within invariant
regions of vlsE and therefore could be unambiguously ’repaired’. Most of these errors
are deletions of guanine within a homopolymer G-run. This demonstrates that like
many other sequencing platforms PacBio may also have difficulties sequencing GC-
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rich, repetitive sequences or stretches of homopolymer DNA. Several other studies
have also reported that deletion errors are twice as common as substitution and
insertion errors in PacBio sequencing [40].
TG insertions (which would result in frameshifts) are found in single locations
of two vls silent cassettes, vls14 and vls16. Otherwise, all other relative indels in the B.
burgdorferi B31 vls cassette regions occur in multiples of three nucleotides, thus
preserving the open reading frame [26]. This same pattern has been found in all
Lyme disease Borrelia vls loci examined [27]. Furthermore, a single-base indel was
found in only one of 1,399 vlsE sequences examined by Coutte et al. [29] by Sanger
sequencing. These findings provide further confidence that the single nucleotide
indels found in the PacBio sequences represent sequence errors.
In this study, manual alignments and sequence corrections were performed
on 486 PacBio sequences to permit evaluation of the frequency and nature of vlsE
recombinations that occurred under the conditions examined. This analysis provided
a view of the previously undetected vlsE variation in axenic cultures, as well as in
tissue explants and in infected mice.
Analyses of axenic cultures samples (2337C and 5A18NP1) revealed that
approximately 1% of the sequences were variant vlsE. According to our hypothesis,
we expected to see a significantly higher number of variants within the tissue explant
co-culture samples than the number of variants detected in axenic culture. Looking at
the number of variants found in samples, there was not a significant difference
between the number of variants found in tissue explant co-culture samples (TE47,
TE49, TE50) and the in vitro mammalian cell free samples (2337C, 5A18NP1). Thus
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the data analyzed to date indicate that the recombination rate in vitro is not
enhanced by the presence of mammalian tissue. It is possible that not all variant
sequences were found using the method of local BLAST to compare the raw reads
against IR-VR regions. Also, alteration of the tissue explant system may result in
higher recombination rates. Therefore, additional analysis is needed to reinforce this
initial finding.
To find the number of variants in mouse infection samples (mouse bladder
tissue 7 days post inoculation), 200 sequences were manually aligned. Fifty-seven
percent of those 200 sequences were found to have alterations. These results are in
agreement with prior studies, which showed ~50% of clones recovered from mice at
7 days post infection had a variant vlsE sequence [27]. The similarity in the number
of variants found in day 7 mouse infection samples in this study and former studies
further help to support PacBio sequencing as a valid method for quantitating the rate
of vlsE recombination.
Across all variant sequences, the majority of the changes occurred within the
proposed variable regions. This result supports prior studies presented in Coutte et
al. [27]. The conserved regions of VlsE may preserve the protein structure or
functionality, serving as a ‘scaffold’ for the variable regions.
Analysis of variants with single well-defined recombination events showed
that the mammalian cell-free in vitro samples had more variants with longer minimal
recombination than the tissue explant co-culture and infected mouse samples. This
distinction could be indicative of a mechanistic difference in vlsE recombination
when in in vitro (axenic samples) and when in the presence of mammalian cells
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(tissue explant co-cultures and mouse infected tissue samples). A different set of
proteins may be involved when vlsE recombination occurs in an in vitro mammalian
cell free environment that results in longer minimal recombination events.
Interestingly, like the variant reads from axenic in vitro sample, the variant vlsE
sequences recovered from ruvAB mutants also had long minimal recombination
events. This observation further supports the proposition that additional proteins
involved in recombination may be expressed and active in the mammalian host than
in an axenic environment.
Some of the single recombination events were template-independent point
mutations. It is not clear whether these are real point mutations caused by genetic
change or sequencing errors. The average quality ratio for variants with a point
mutation as the single well defined recombination event was lower than the average
quality ratio for the remaining variants with a single recombination event (data not
shown). Therefore, it is likely that some the point mutations are sequencing errors.
VlsE has not been shown to have a function other than helping B. burgdorferi
evade host immune response by varying its sequence. It is also possible that the
proteins required for an increase vlsE recombination rate are activated at specific
environmental conditions such as pH, temperature, and osmolarity. Previous studies
have shown that vlsE recombination can occur within SCID mice, and therefore the
adaptive immune response does not play a role in the induction of vlsE
recombination [33]. It is also unlikely that host proteins are internalized by B.
burgdorferi and are used in vlsE recombination because that would require the host
proteins to penetrate the bacterial membrane. Interaction between specific host
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proteins and the surface exposed VlsE may be required to activate the proteins that
play a role in increasing the rate of vlsE recombination in the mammalian host.
Conclusion and future perspectives
In this study, we developed a protocol using PacBio sequencing to identify
real vlsE variants in samples from mammalian cell-free in vitro cultures, tissue
explant co-cultures and mouse infection studies. High-throughput sequencing
generated large amounts of data that allowed us to detect rare recombination events.
vlsE recombination has been shown to occur in random segmental changes that can
include a single base change to almost the entire cassette. Therefore, the study of vlsE
variants is sensitive to sequencing errors. Despite the PacBio sequencing results
being hampered by errors, we were able to unambiguously fix a majority of the
errors.
There seems to be an intrinsic low level of vlsE recombination occurring in
axenic cultures, which is enhanced when in mammalian host. We found that the
length of a recombination event in variant sequences with a single well defined
recombination event were longer in mammalian cell-free samples than in tissue
explant and mouse infection samples. This may be the result of a different set of
proteins being activated during vlsE recombination in in vitro and in in vivo. We also
developed a qPCR assay that is a sensitive and relatively simple means of assessing
the frequency of vlsE recombination in a sample. The qPCR results corroborate the
PacBio sequencing results, as both methods detected the occurrence of vlsE variation
in axenic cultures and showed increases during mouse infection. Also, both
approaches indicated that there was not a significant difference between the number

65

of variants found in the mammalian cell-free and the tissue explant co-culture
samples.
It might be possible to increase the sensitivity of the qPCR assay by
standardizing tissue weight prior to DNA extraction. For the next sequencing
experiments, we will be looking into whether there is a difference in the error rate
between the SMRTbell sequencing of the sense and antisense strand of a single
molecule. If there is a significant difference, averaging the strand with the lower
error rate will result in a higher quality consensus read.
The remaining samples from mouse infection studies will be sequenced and
analyzed. This includes joint, bladder, heart, skin, and ear tissue samples from days 7,
14, 28, 60, and 90 post infection. To further understand the effect of passage number
on the number of variants detected in mammalian cell-free in vitro culture, we will be
sending clone samples that have undergone 1-10 passages. We also plan to sequence
another B. burgdorferi gene with the same GC content as vlsE. This approach will
allow us to better measure the error rate in PacBio sequencing. We will be using the
automation program to align sequences and make error corrections.
Furthermore, the protocol developed in this study using PacBio highthroughput sequencing and qPCR to study vlsE recombination could be applied to
study other antigenic variation systems. For example, Neisseria gonorrhoeae, the
causative agent of the sexually transmitted disease gonorrhea, varies its pilE
sequence. Other examples are the previously described T. brucei system, the Vlp
family of lipoproteins in Mycoplasma hyrohini, and Msp2 antigenic variation in
Anaplasma phagocytophilum [41].
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